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Background: KDIGO (Kidney Disease: Improving Global Outcomes) guidelines recommend that a lateral abdominal
radiograph should be performed to assess vascular calcification (VC) in dialysis patients. However, abdominal aortic
calcification is a prevalent finding, and it remains unclear whether other anatomical areas of VC can predict
mortality more accurately.
Methods: A total of 217 maintenance hemodialysis patients were enrolled at the Sichuan Provincial People’s
Hospital between July 2010 and March 2011. Radiographs of the abdomen, pelvis and hands were evaluated by a
radiologist to evaluate the presence of VC. The correlation between different areas of VC and all-cause or
cardiovascular mortality was analyzed using univariate and multivariate models.
Results: The prevalence of VC was 70.0% (152 patients), and most had abdominal aortic calcification (90.1%).
During 26 ± 7 months of follow-up, 37 patients died. The VC score was independently associated with patient
mortality. VC observed on abdominal radiographs (abdominal aortic calcification) was associated with all-cause
mortality in models adjusted for cardiovascular risk factors (HR, 4.69; 95%CI, 1.60-13.69) and dialysis factors (HR, 3.38;
95%CI, 1.18-9.69). VC in the pelvis or hands was associated with all-cause mortality in the model adjusted for dialysis
factors. When three combinations of VC in different radiographs were included in models, the presence of
abdominal VC was only significantly associated with all-cause mortality in the integrated model. VC in the abdomen
and pelvis was associated with all-cause mortality in the model adjusted for cardiovascular factors and the
integrated model, but neither was significantly associated with cardiovascular mortality. VC in all radiographs was
significantly associated with a more than 6-fold risk of all-cause mortality and a more than 5-fold risk of
cardiovascular mortality compared to patients without VC.
Conclusions: VC in different arteries as shown on radiographs is associated with different levels of risk for mortality.
The lateral abdominal radiograph may not be superior to other radiographs for predicting patient outcomes.
Further research is needed to elucidate the effects of difference burdens of VC on patient outcomes.
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Cardiovascular mortality is reported to be the leading cause
of mortality among patients undergoing hemodialysis [1,2].
Besides traditional risk factors for cardiovascular disease,
mineral bone disorders associated with chronic renal dis-
ease, and vascular calcifications (VC) in particular, have
been identified as disease-specific risk factors for cardiovas-
cular disease (CVD) in hemodialysis patients [3-5]. In clin-
ical observations, a strong relationship between coronary
artery calcification and cardiovascular mortality has been
reported in hemodialysis patients [6-9]. However, due to its
high cost and radiation exposure, computed tomography
(CT) is not recommended as a routine or screening tech-
nique for VC. Kidney Disease: Improving Global Outcomes
(KDIGO) has recommended that a lateral abdominal radio-
graph and echocardiography should be used as appropriate
alternatives to cardiac CT to detect VC [10]. However, as a
result of the high prevalence of abdominal VC in both
hemodialysis patients and the elderly population in general
[11-14], its clinical value may be limited. Other vascular
calcifications by radiographs have been reported, but except
for coronary artery calcification,whether a more specific VC
exists to predict patient outcomes than abdominal aortic
calcification remains unclear.
Although a significant relationship between abdominal
aortic calcification and patient mortality has been
reported, most studies have described the presence of VC
only in a specific artery. The mechanisms and speed of
VC development, its pathophysiology, accompanying risk
factors and impact on patient outcomes may differ to
some degree between arteries. Few studies have analyzed
the confounding effects of different regions of VC on the
prognosis of hemodialysis patients. One study showed that
both coronary artery calcification (HR, 3.40; 95%CI, 1.24-
9.36) and aortic arch calcification (HR, 6.23; 95%CI, 1.64-
23.66) remained significantly associated with mortality
after they were adjusted for each other [6]. A simple scor-
ing system to evaluate VC in hemodialysis patients has
identified a positive correlation between outcomes and
this VC score [15]. However, if VC in different arteries
contributes differently to patient outcomes, this scoring
system will need appropriate adjustment.
We hypothesized that different regions of VC have dif-
ferent levels of impact upon patient mortality, and that
abdominal radiographs may not be the best choice for
this evaluation. We analyzed lateral abdominal, frontal
pelvic and bilateral hand radiographs to ascertain the de-
gree of predictive value for patient outcomes, with par-
ticular emphasis on cardiovascular mortality.
Methods
Study design
This was a retrospective, single-center study of patients
undergoing hemodialysis.Participants
We enrolled all hemodialysis patients who had received
dialysis 3 times/week for >3 months. Treatment of
patients with chronic kidney disease mineral bone
disorders (including secondary hyperparathyroidism) in-
cluded management of hyperphosphatemia by restric-
tion of diet phosphorus intake (as recommended by a
dietitian), calcium-based phosphorus binders (calcium
carbonate or calcium acetate), and non-calcium phos-
phorus binders (sevelamer, lanthanum carbonate or
temporary use of sucralfate); management of serum cal-
cium by calcium carbonate with/without alfacalcidol/
calcitriol); and management of iPTH by alfacalcidol or
calcitriol. Patients with hypertension were treated with
single drugs or different combinations of calcium chan-
nel blockers, beta- adrenoreceptor blockers, angiotensin
converting enzyme inhibitors, and angiotensin receptor
blockers. Radiographs (lateral abdominal radiograph,
frontal pelvic radiograph and both hands) were taken
between July 2010 and March 2011 at the Blood Purifi-
cation Center in Sichuan Provincial People’s Hospital.
Patients without records of laboratory investigations
during this period were excluded. This study was ap-
proved by the Sichuan Academy of Medical Sciences
and the Sichuan Provincial People’s Hospital Medical
Ethics Committee (reference number: 2011KY-SN01).
In total, 217 patients were enrolled and each signed an
informed consent prior to the study.
Measurements
The radiographs (computed radiography XG-1, Fuji,
Japan) were reviewed by an independent radiologist. The
pelvic radiographic films were divided into four sections
by two lines: a horizontal line over the upper limit of
both femoral heads and a median vertical line over the
vertebral column. The films of each hand were divided
by a horizontal line over the upper limit of the metacar-
pal bones [15]. The lateral abdominal radiographs were
divided into two sections by a horizontal line over the
intervertebral space between L2 and L3. The presence of
linear calcifications in each section was counted as 1 and
their absence was counted as 0. The final score was
taken as the sum of all sections, and ranged from 0 to
10. VCs were evaluated in the iliac, femoral, radial digital
and abdominal aortic arteries (Figures 1, 2 and 3).
Covariates
Data regarding the demographic characteristics, history
of diabetes, hypertension, stroke, hyperlipidemia, coron-
ary artery disease, peripheral arterial disease and the
duration of dialysis were collected from the records of
patients in our Blood Purification Center. Blood pres-
sures were measured before three dialysis sessions after
a period of quiet supine rest using an Omron electronic
Figure 1 Vascular calcification evident on pelvic radiograph.
Figure 3 Vascular calcification in an abdominal radiograph.
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pulse pressures were then calculated.
10 ml of blood sample was drawn before starting a dia-
lysis session for pre-dialysis measurements and 4 ml of
blood sample was drawn at the end of dialysis session for
post-dialysis measurements. Biochemical variables were
measured using the Mindray BS-420 automatic biochem-
ical analyzer. Pre-dialysis serum concentrations of creatin-
ine, blood urine nitrogen, alkaline phosphatase, albumin,
total cholesterol, triglycerides, calcium and phosphorus
and post-dialysis concentrations of blood urine nitrogen
were measured using routine laboratory methods. Kt/V
was utilized to evaluate the adequacy of hemodialysis. Pre-
dialysis parathyroid hormone (PTH) and ferritin (FER)
levels were detected by chemiluminescence using a Sie-
mens IMMULITE 1000 fully-automated chemilumines-
cence immunoassay analyzer with Siemens ancillary
reagents. Pre-dialysis hemoglobin was measured using
a SLS hemoglobin detection method with a MindrayFigure 2 Vascular calcification in radiographs of the hand.BC5500 automated blood cell analyzer. Mean values of 3
measurements of serum calcium, phosphorus, albumin,
alkaline phosphatase, and hemoglobin were calculated,
other parameters were single measurements and acquired
at the beginning of the study. Hyperlipidemia was defined
as a total cholesterol level >200 mg/dL, a triglyceride level
>150 mg/dL or the use of any lipid-lowering medication.
Outcomes
Patient deaths during the study period were determined
from a review of the Sichuan Provincial People’s Hospi-
tal’s data according to the CNRDS database (www.cnrds.
net) or records at the Blood Purification Center. These
included deaths that occurred in hospital or outside hos-
pital. Cardiovascular mortality was defined as death due
to myocardial infarction, heart failure, sudden cardiac
death, or stroke. All-cause and cardiovascular mortality
rates were calculated.
Statistical methods
Baseline characteristics were compared between patients
who survived or died during the follow-up period. De-
scriptive statistics are presented as the mean ± standard
deviation or median with 25th-75th percentile. Differ-
ences in the mean and median values between groups
were evaluated using the independent t-test and the
Mann–Whitney U test, respectively. Categorical data
Table 1 Baseline characteristics of participants
Variables All (n = 217) Alived (n = 180) Deceased (n = 37) P
Age (y) 60 ± 16 57 ± 15 72 ± 10 <0.001
Male (%) 49.8 47.8 59.5 0.20
Cardiovascular disease (%) 12.9 12.2 16.2 0.51
Cerebral vascular disease (%) 7.4 6.1 13.5 0.12
History of hypertension (%) 88.5 90.5 81.1 0.10
Diabetes mellitus (%) 27.6 24.4 43.2 0.02
Dialysis vintage (m) 46 ± 41 46 ± 41 47 ± 43 0.89
Hyperlipidemia (%) 57.1 58.1 54.1 0.65
SBP (mm Hg) 144.7 ± 19.3 144.5 ± 18.8 145.2 ± 21.7 0.86
DBP (mm Hg) 76.1 ± 11.4 77.3 ± 11.0 70.4 ± 11.5 0.001
PP (mm Hg) 68.5 ± 17.3 67.2 ± 17.0 74.8 ± 17.8 0.02
Calcium (mmol/L) 2.22 ± 0.23 2.21 ± 0.23 2.26 ± 0.25 0.25
<2.10 (%) 31.5 32.4 27.0
2.10-2.37 (%) 46.8 47.5 43.2
>2.37 (%) 21.8 20.1 29.7 0.43
Phosphorus (mmol/L) 1.81 ± 0.59 1.81 ± 0.57 1.78 ± 0.64 0.78
<1.13 mmol/L (%) 10.2 8.4 18.9
1.13-1.78 mmol/L (%) 44.4 45.8 37.8
>1.78 mmol/L (%) 45.4 45.8 43.2 0.15
PTH (pg/ml) 286(174–598) 301(185–603) 227.0(107–516) 0.20
<150 (%) 20.8 19.0 29.7
150-300 (%) 30.1 30.7 27.0
>300 (%) 49.1 50.3 43.2 0.34
ALP (U/L) 103.72 ± 58.35 101.85 ± 57.76 112.81 ± 61.13 0.30
Albumin (g/L) 40.0 ± 3.1 40.3 ± 2.8 38.3 ± 3.9 0.01
Kt/V 1.34 ± 0.34 1.36 ± 0.35 1.20 ± 0.22 0.01
Hb (g/L) 105.94 ± 20.81 105.68 ± 22.06 104.35 ± 21.82 0.74
Calcification score 2(0–3) 1(0–3) 4(2–6) <0.001
Aorta calcification (%) 63.1 57.8 89.2 <0.001
Iliac artery calcification (%) 34.1 28.9 59.5 <0.001
Femoral artery calcification (%) 16.6 12.2 37.8 <0.001
Digital artery calcification (%) 7.8 5.6 18.9 0.01
Radial artery calcification (%) 19.8 17.8 29.7 0.10
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressure, PP Pulse pressure, PTH Parathyroid hormone, ALP Alkaline phosphatase, Hb Hemoglobin.
Hong et al. BMC Nephrology 2013, 14:120 Page 4 of 11
http://www.biomedcentral.com/1471-2369/14/120was compared between groups with the chi-square test.
Covariates with P-values <0.10 in the univariate analysis
and with biological plausibility were included in our
multivariate models. Survival curves were estimated with
the Kaplan-Meier method and evaluated using the log-
rank test to determine the difference in survival rates
between groups with or without different VCs. Inde-
pendent hazard ratios of all-cause and cardiovascular
mortality associated with different VCs and different
combinations of VCs were analyzed by the Cox propor-
tional hazard regression for four different models. Model1 was adjusted for demographic variables (age and gen-
der); model 2 was adjusted for traditional cardiovascular
risk factors (age, CAD, diabetes, hyperlipidemia and
hypertension); model 3 was adjusted for dialysis specific
factors (age, phosphorus level, Kt/V, albumin level, PTH
level and duration of dialysis); and model 4 included co-
variates with P-values <0.10 in the univariate analysis
(age, diabetes, phosphorus level, albumin level, hyperten-
sion, Kt/V, and pulse pressure). IBM SPSS statistical
software (version 19.0, SPSS Inc., Chicago, IL, USA) was
used to analyze all the data.
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The average age of the participants was 60 ± 16 years,
and 49.8% were men. The prevalence of VC was 70.0%
(152 patients), and its prevalence in the abdominal aorta,
iliac artery, femoral artery, digital artery and radial artery
were 63.1%, 34.1%, 16.6%, 7.8% and 19.8% respectively
(Table 1). Among the 152 patients with VC, only 15 pa-
tients (approximately 10%) did not have calcification of
the abdominal aorta. During the follow-up period of 26 ±
7 months, 37 patients (17.1%) died, of whom 23 patients
died of cardiovascular disease.
The patients that died were older (72 ± 10 vs. 57 ±
15 years, P < 0.001), more often diabetic (43.2% vs.
24.4%, P = 0.02), had lower serum albumin levels (38.3 ±
3.9 g/L vs. 40.3 ± 2.8 g/L, P = 0.01), lower diastolic blood
pressure levels (70.4 ± 11.5 mmHg vs. 77.3 ± 11.0 mmHg,
P = 0.01), higher pulse pressures (74.8 ± 17.8 vs. 67.2 ±
17.0 mmHg, P = 0.02), and lower Kt/V (1.20 ± 0.22 vs.
1.36 ± 0.35, P = 0.01) compared to patients who survived
during the follow-up period. They also had a higher
prevalence of different VCs and higher overall VC scores
(Table 1).
Participants with VCs in different areas were at a
greater risk of death (all-cause or cardiovascular) in the
unadjusted analysis (Figures 4 and 5) with an increasing
trend with increasing VC scores (Table 2). In the Cox re-
gression (Tables 3 and 4), the VC score was independ-
ently associated with all-cause and cardiovascular
mortality in models 2 and 3 (adjusted for cardiovascular
risk factors [HR, 1.23; 95%CI, 1.09-1.39 and HR, 1.24;
95%CI, 1.07-1.43] and dialysis-related risk factors [HR,
1.26; 95%CI, 1.11-1.43 and HR, 1.30; 95%CI, 1.11-1.51],
respectively).
In the Cox regression analysis (Tables 3 and 4), ab-
dominal aortic VCs were associated with all-cause mor-
tality in model 2 adjusted for cardiovascular risk factorsFigure 4 Kaplan-Meier curves for patients with and without vascular(HR, 4.69; 95%CI, 1.60-13.69) and in model 3 adjusted
for dialysis-related factors (HR, 3.38; 95%CI, 1.18-9.69),
but were not significantly associated with cardiovascular
mortality in all models. VCs observed in pelvic radio-
graphs (iliac artery or femoral artery calcification) were
associated with all-cause mortality in model 3 (HR, 2.23;
95%CI, 1.07-4.66). VCs observed in the hand radio-
graphs (digital artery or radial artery calcifications) were
associated with all-cause mortality in model 3 (HR, 2.06;
95%CI, 1.02-4.20). VCs observed in the pelvic or hand
radiographs were not significantly associated with car-
diovascular mortality. Overall, digital artery calcifications
remained significantly associated with all-cause or car-
diovascular mortality in all four models.
In order to study the different contribution to patient
mortality by VCs in different regions, we calculated the
frequency of different combinations of the above three
radiographs; combinations with a frequency of less than
15 were excluded to avoid over-specification. As a result
of the high prevalence of abdominal aorta calcifications,
only three combinations were ultimately selected. These
were as follows: (A) VC in the abdominal radiograph
(n = 53 patients); (A+P) VC present in both the abdom-
inal and pelvic radiographs (n = 46 patients); and (A+P
+H) VC present in abdominal, pelvic and hand radio-
graphs (n = 26 patients). When the three combinations
were each entered into the models as a categorical vari-
able (Tables 3 and 4), compared with patients without
VC, ‘A’ was only significant for all-cause mortality in
model 4, VC observed in ‘A+P’ was associated with all-
cause mortality in cardiovascular risk factors adjusted
model (model 2) and in model 4, while ‘A+P+H’ was sig-
nificantly associated with an increase in all-cause mortal-
ity of more than 6-fold and an increase in more than
5-fold for cardiovascular mortality compared to patients
without VCs in any of the radiographs. ‘A’ or ‘A+H’ VCscalcification. A) All-cause mortality; B) cardiovascular mortality.
Figure 5 Kaplan-Meier curves for patients with and without abdominal aortic calcification. A) All-cause mortality; B) cardiovascular
mortality.
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vascular death in this study.
Discussion
The prevalence of VC in our study was 70.0%, and al-
though there were some differences from previous stud-
ies because of the different evaluation methods used, the
finding of a high prevalence of VC in hemodialysis pa-
tients was consistent with most studies [8,15,16]. Our
study showed an increased risk of all-cause and cardio-
vascular mortality with higher VC scores, which was
consistent with most previous studies [15,17-19]. Our
results showed a positive correlation between all-cause
mortality and abdominal aortic VC, after adjustment for
different VC combinations. This was only significant for
the cardiovascular risk factor adjusted model and the in-
tegrated model, and no significant results were found
with regards to cardiovascular mortality. VC present in
‘A+P’ was significantly associated with all-cause mortality
only in the model adjusted for cardiovascular risk fac-
tors, while ‘A+P+H’ VCs showed significantly higher
hazard ratios (HR) for all-cause or cardiovascular mor-
tality in all models (5-fold and 4-fold, respectively, com-
pared to patients without VC). This could have resulted
from the additive effect of an increasing VC score, or
the independent effect of the additional VCs observed in
the radiographs of the hands.
The prevalence of aortic calcification has been
reported to be more than 50% in CKD patients [5,6,11],
which is in accordance with our results. This may be as-
sociated with several risk factors, including increasing
age [12], genetic factors [20] and body composition [21]
in addition to traditional cardiovascular risk factors and
CKD/dialysis-related risk factors. Therefore, this may de-
crease its ability to distinguish disease related status that
could cause poor outcomes from the effect of natural
aging, or its clinical value might be overestimated when
effects of other coexisting VCs are included. In our cen-
ter, we did not find a constant positive associationbetween abdominal aortic calcification and all-cause or
cardiovascular mortality in all models after adjusting for
VC present in other radiographs combinations, while a
significant association between all-cause and cardiovas-
cular mortality and VC present in all three radiographic
sites was observed. Although the additive risk may be
due to the total VC score, the probability of an inde-
pendent effect of VC observed in hand radiographs can-
not be excluded. It follows from the above that if
abdominal aortic calcification is solely analyzed without
coexisting VCs, the risk for patient death would be
overestimated. Many studies have revealed a significant
association between aortic calcification and patient
mortality [5,6,22-24], but few studies have focused on
the independent effect on patient survival of VCs in dif-
ferent anatomical sites. A more accurate method of
measuring the systemic burden of VCs could be devel-
oped to optimize risk stratification in high-risk dialysis
patients [6].
We did not find a significant association between pa-
tient mortality and radial artery calcification in either
the univariate or multivariate analysis. We have little
insight into the relationship between radial artery calcifi-
cation and patient death, with the exception of a single
study by Schlieper et al. [25]. They reported an increased
risk (HR, 2.15; 95%CI, 1.05-4.39, P = 0.036) for patient
mortality with vascular access calcification after their
analysis was adjusted for age, diabetes, duration of dialy-
sis and pre-existing vascular disease. However, they also
reported a positive correlation between the presence of
other VCs (femoral/iliac) and vascular access calcifica-
tion, which makes it more difficult to distinguish be-
tween the independent influences on patient outcome by
different VCs. Risk factors for radial artery calcification
are more complicated than for other VC sites, including
the effects of arteriovenous fistula (AVF) construction,
hemodynamic factors and inadequate dialysis [26-28].
Although we found a lower prevalence of radial artery
calcification than AVF calcification by CT fistulogram
Table 2 Univariate analysis of risk for all-cause and cardiovascular mortality
Variable HR for all-cause
mortality (95%CI)
P-value HR for cardiovascular
mortality (95%CI)
P-value
Age (per 1-yr older) 1.08(1.05-1.11) <0.001 1.06(1.03-1.10) 0.01
Male (compared to female) 1.55(0.80-2.98) 0.19 1.14(0.51-2.59) 0.75
History of cardiovascular disease 1.26(0.53-3.02) 0.61 0.97(0.29-3.25) 0.95
History of cerebral vascular disease 2.03(0.79-5.22) 0.18 1.92(0.57-6.47) 0.29
Dialysis vintage (per 3-m longer) 1.00(0.98-1.03) 0.90 1.00(0.97-1.03) 0.89
Diabetes mellitus 2.13(1.11-4.07) 0.02 3.00(1.32-6.80) 0.01
Phosphorusa
<1.13 mmol/L 2.38(0.96-5.89) 0.06 2.81(1.02-7.73) 0.05
>1.78 mmol/L 1.11(0.54-2.27) 0.78 0.68(0.26-1.79) 0.44
Calciumb
<2.10 mmol/L 0.92(0.42-2.03)) 0.84 0.883(0.32-2.43) 0.81
>2.37 mmol/L 1.54(0.72-3.32) 0.27 1.55(0.59-4.08) 0.37
PTHc
<150 pg/ml 1.67(0.71-3.93) 0.24 1.51(0.49-4.67) 0.48
>300 pg/ml 1.01(0.46-2.22) 0.9 1.16(0.43-3.12) 0.78
ALP 1.00(1.00-1.01) 0.27 1.00(1.00-1.00) 0.27
Hyperlipidemia 0.87(0.46-1.67) 0.68 1.15(0.50-2.66) 0.74
Albumin (per 1 g/L increase) 0.83(0.75-0.92) <0.001 0.79(0.70-0.90) <0.001
Hemoglobin (per 1 g/L increase) 1.00(0.98-1.01) 0.55 1.00(0.98-1.01) 0.55
History of hypertension 0.46(0.20-1.05) 0.06 0.39(0.14-1.05) 0.06
Kt/V (per 1 increase) 0.18(0.06-0.59) 0.01 0.241(0.05-1.08) 0.06
Presence of aorta calcification 5.33(1.89-15.04) 0.01 3.03(1.03-8.93) 0.04
Presence of iliac artery calcification 3.15(1.64-6.08) 0.01 2.76(1.21-6.29) 0.02
Presence of femoral artery calcification 3.66(1.88-7.12) 0.01 2.61(1.15-5.92) 0.02
Presence of digital artery calcification 3.43(1.51-7.83) 0.01 5.03(1.98-12.76) 0.01
Presence of radial artery calcification 1.87(0.92-3.78) 0.08 1.92(0.79-4.66) 0.15
Presence of iliac or femoral artery calcification 3.05(1.57-6.00) 0.01 2.85(1.24-6.60) 0.01
Presence of radial or digital artery calcification 2.15(1.10-4.23) 0.03 2.52(1.09-5.83) 0.03
Vascular calcification score (per 1 score increase) 1.28(1.16-1.42) <0.001 1.29(1.14-1.47) <0.001
Pulse pressure (per 1 mmHg increase) 1.02(1.00-1.04) 0.01 1.22(1.00-1.04) 0.09
a Compared with a reference group of 1.13-1.78 mmol/L; b compared with a reference group of 2.10-2.37 mmol/L; c compared with a reference group
of 150–300 pg/ml.
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of the radial artery (including the vessels used for AVF)
because of the limitations of hand radiography which in-
cluded only part of the forearm. This may partly explain
the inconsistent findings in our study. Calcification of
the radial artery may lead to the failure of vascular ac-
cess maturation [29]. Moreover, digital artery calcifica-
tion and the presence of VC in hand radiographs
(whether adjusted for other VCs or not) was significantly
associated with all-cause and cardiovascular mortality.
Therefore, hand radiographs may be conducted before
AVF surgery to avoid subsequent failure as a result offistula blockages. It could be an investigative method for
identifying patients at high risk of death. Further studies
need to be performed to confirm this finding and to
compare it with coronary artery calcification, the gold
standard VC for patient outcomes.
VCs in the femoral or iliac arteries was correlated
with an increased risk of all-cause mortality in both the
univariate and multivariate analysis. Iliac artery calcifi-
cation was significantly associated with all-cause mor-
tality, while it was not significantly associated with
cardiovascular mortality in the multivariate analysis in
our study, which was consistent with previous research
Table 3 Relationship between vascular calcifications and all-cause mortality in hemodialysis patients
VC scorea Abdominal radiograph Pelvic radiography Hand radiographs Ac A+Pc A+P+Hc
Aorta VCb Allb Iliac VCb Femoral VCb Allb Digital VCb Radial VCb
Model 1 1.24(1.10-1.40) 3.27(1.15-9.30) 1.91(0.96-3.79) 1.97(1.00-3.88) 2.33(1.18-4.57) 1.98(1.01-3.90) 3.32(1.44-7.67) 1.83(0.90-3.74) 2.76(0.74-10.23) 2.94(0.80-10.78) 6.76(1.86-24.55)
Model 2 1.23(1.09-1.39) 4.69(1.60-13.69) 1.88(0.94-3.76) 1.99(1.00-3.96) 2.23(1.11-4.45) 1.50(0.72-3.13) 2.68(1.11-6.50) 1.35(0.63-2.88) 3.81(0.98-14.83) 3.90(1.02-14.88) 6.14(1.66-22.67)
Model 3 1.26(1.11-1.43) 3.38(1.18-9.69) 2.23(1.07-4.66) 2.24(1.09-4.60) 3.22(1.55-6.70) 2.06(1.02-4.20) 3.37(1.43-7.91) 1.79(0.85-3.77) 2.65(0.70-10.00) 2.96(0.80-10.99) 7.48(1.97-28.45)
Model4 1.25(1.10-1.41) 4.47(1.55-12.92) 2.32(1.11-4.82) 2.34(1.15-4.78) 3.09(1.49-6.42) 1.60(0.76-3.37) 2.62(1.04-6.58) 1.36(0.63-2.95) 4.38(1.09-17.58) 4.35(1.12-16.90) 7.43(2.01-27.44)
Notes: a Total vascular calcification score per 1 point score increase; b vascular calcification present in either artery; c vascular calcification present in abdominal radiographs, in both abdominal and pelvic radiographs,
and in all radiographs (abdominal, pelvic and bilateral hand radiographs) compared to participants without any vascular calcifications in all radiographs.
Model 1: adjusted for age and gender.
Model 2: adjusted for age, CAD, hypertension, diabetes and hyperlipidemia.
Model 3: adjusted for age, phosphorus level, Kt/V, albumin level, PTH level and duration of dialysis.
Model 4: adjusted for age, diabetes, phosphorus level, albumin level, hypertension, Kt/V and pulse pressure.



















Table 4 Relationship between vascular calcifications and cardiovascular mortality in hemodialysis patients
VC scorea Abdominal radiograph Pelvic radiograph Hands radiographs Ac A+Pc A+P+Fc
Aorta VCb Allb Iliac VCb Femoral VCb Allb Digital VCb Radial VCb
Model 1 1.25(1.08-1.45) 1.97(0.66-5.88) 1.85(0.77-4.43) 1.79(0.76-4.21) 2.50(1.05-5.91) 2.30(0.99-5.32) 4.52(1.76-11.60) 1.88(0.77-4.60) 1.91(0.48-7.70) 1.09(0.24-5.08) 5.53(1.46-21.00)
Model 2 1.24(1.07-1.43) 3.12(0.99-9.79) 1.92(0.80-4.61) 1.94(0.82-4.59) 2.36(0.98-5.70) 1.54(0.64-3.70) 3.43(1.27-9.28) 1.21(0.48-3.02) 2.86(0.65-12.60) 1.70(0.34-8.39) 5.01(1.30-19.29)
Model 3 1.30(1.11-1.51) 2.01(0.66-6.13) 2.42(0.94-6.25) 2.24(0.90-5.58) 3.60(1.42-9.14) 2.28(0.94-5.54) 5.50(2.04-14.85) 1.64(0.64-4.22) 1.68(0.41-6.93) 1.29(0.27-6.26) 6.08(1.47-25.09)
Model 4 1.27(1.10-1.48)) 2.86(0.93-8.81) 2.56(1.00-6.60) 2.39(0.96-5.93) 3.06(1.39-9.34) 1.64(0.67-4.00) 4.11(1.44-11.77) 1.20(0.47-3.06) 3.07(0.68-13.80) 2.06(0.41-10.40) 6.20(1.59-24.14)
Notes: a total vascular calcification score per 1 point score increase; b vascular calcification present compared to absent in either artery; c vascular calcification present in abdominal radiograph, in both abdominal and
pelvic radiographs, and in all radiograph (abdominal, pelvic, forearm and hand radiographs) compared to participants without any vascular calcifications in all radiographs.
Model 1: adjusted for age and gender.
Model 2: adjusted for age, CAD, hypertension, diabetes and hyperlipidemia.
Model 3: adjusted for age, phosphorus level, Kt/V, albumin level, PTH level and duration of dialysis.
Model 4: adjusted for age, diabetes, phosphorus level, albumin level, hypertension, Kt/V and pulse pressure.



















Hong et al. BMC Nephrology 2013, 14:120 Page 10 of 11
http://www.biomedcentral.com/1471-2369/14/120in a large population with longer follow-up durations
[30]. Moreover, iliac vessel calcification was reported to
be associated with mortality in renal transplant patients
[31], and the plain X-ray of the pelvis was a useful
screening tool to identify patients requiring further de-
tailed vascular imaging before transplantation. This
could be of value in choosing the ‘landing site’ for im-
plantation or to exclude patients not suitable for trans-
plantation. Therefore, it would make sense if pelvic
radiography was carried out as a screening method for
hemodialysis patients at high risk of death from all causes
or those on the waiting list for renal transplantation.
There were several limitations in our study. Firstly, the
study sample was relatively small. The number of VCs
present in different combinations, especially those with-
out abdominal aortic calcification, was relatively small to
distinguish the effect on patient mortality of different
groups. Secondly, the semi-quantification of VCs was
relatively simple, but since VC was not quantitated in
specific arteries, important information may have been
missed. Thirdly, other types of VC were not evaluated in
this study because of the difficulty in differentiating in-
timal calcification from tunica media calcification by
plain X-rays, and this has previously been shown to be
relevant [32]. Finally, the follow-up period was relatively
short compared to similar studies, and with the limita-
tion of retrospective studies including incomplete infor-
mation about comprehensive treatment and compliance,
our findings should be confirmed in future prospective
observational studies.
The strength of the study is its ability to provide com-
parative information concerning the associations of VC at
different arterial sites with all cause and cardiovascular
mortality. We found that abdominal aortic calcification
alone was not a good predictor of patient mortality in our
population, which differed from most previous studies,
but a strong association was found between mortality and
concurrent VC in the abdomen, pelvis and hands. And it
should stimulate expansion of this focus.
Conclusions
In summary, VC is prevalent in hemodialysis patients
and is associated with all-cause and cardiovascular mor-
tality. VCs in different arteries carry different mortality-
related risks. Abdominal aorta calcification is highly
prevalent, which may decrease its prognostic value for
the survival of hemodialysis patients. In this group of
HD patients, with a short follow-up, abdominal vascular
calcification was highly prevalent but was not shown to
be a superior prognostic tool over other vascular area
evaluated. VCs present on hand radiographs appear to
be more closely associated with patient mortality, but
this needs to be confirmed by future studies with larger
sample sizes and different combinations of VC sites.Abbreviations
VC: Vascular calcification; CVD: Cardiovascular disease; AVF: Arteriovenous
fistula.
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